0001209191-23-011047.txt : 20230221
0001209191-23-011047.hdr.sgml : 20230221
20230221123845
ACCESSION NUMBER: 0001209191-23-011047
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230216
FILED AS OF DATE: 20230221
DATE AS OF CHANGE: 20230221
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Kashmolah Ghazi
CENTRAL INDEX KEY: 0001877741
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39976
FILM NUMBER: 23646724
MAIL ADDRESS:
STREET 1: 1412 62ND STREET
CITY: EMERYVILLE
STATE: CA
ZIP: 94608
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Lucira Health, Inc.
CENTRAL INDEX KEY: 0001652724
STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835]
IRS NUMBER: 272491037
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 1315 63RD STREET
CITY: EMERYVILLE
STATE: CA
ZIP: 94608
BUSINESS PHONE: (814) 574-1546
MAIL ADDRESS:
STREET 1: 1315 63RD STREET
CITY: EMERYVILLE
STATE: CA
ZIP: 94608
FORMER COMPANY:
FORMER CONFORMED NAME: DiAssess Inc.
DATE OF NAME CHANGE: 20150908
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2023-02-16
1
0001652724
Lucira Health, Inc.
LHDX
0001877741
Kashmolah Ghazi
1412 62ND STREET
EMERYVILLE
CA
94608
0
1
0
0
Ex VP & Chief Quality Officer
Common Stock
2023-02-16
4
S
0
5028
0.27
D
134075
D
These shares were sold by the reporting person to cover tax withholding obligations in connection with the vesting of Restricted Stock Units
granted on September 30,2021 for 197,240 shares.
/s/ Richard Narido, Attorney-in-Fact for Ghazi Kashmolah
2023-02-21